Study Objectives: Sleep disturbances are common in acute stroke patients and are linked with a negative stroke outcome. However, it is also unclear which and how such changes may be related to stroke outcome. To explore this link, we performed a sleep electroencephalogram (EEG) study in animals and humans after ischemic stroke.
Introduction
Sleep is mediated by several mechanisms which are important for brain and body health [1] . Sleep plays a role not only in the maintenance of wakefulness, but also in energy conservation [2] , thermoregulation [3] , memory consolidation [4, 5] , neuronal plasticity [6, 7] , tissue restoration and inflammation [8, 9] .
For different reasons sleep could have an impact on stroke evolution and outcome. Sleep is associated with a general decrease in metabolism and a reduction in body temperature [10] which both enhance neuroprotection. Furthermore, sleep plays an important role in modulating inflammation and apoptotic processes [1, 11, 12] , both of which affect stroke evolution. Finally, sleep promotes neuroplasticity, which underlies neurorehabilitation effects.
In humans, several studies have shown detrimental effects of sleep disorders on stroke outcome and conversely favorable effects of treatment of sleep disorders [13, 14] . Siengsukon et al. [15, 16] have shown that stroke patients, but not healthy controls, improve their performance in an implicit and explicit motor learning task following a period of sleep and that the magnitude of improvement is associated with the amount of time spent in REM sleep. Sarasso et al. [17] have shown that acute logopedic interventions after stroke are accompanied by an overnight improvement of speech which parallels an increase in local slow-wave activity. Despite the increasing evidence of a role of sleep for stroke outcome, sleep disorders are neglected and underdiagnosed in stroke patients [18] [19] [20] .
In animal models of stroke, sleep disruption/loss has similarly been shown to have a negative impact on stroke outcome and poststroke neuroplasticity processes [21] . Conversely, sleep promotion was found to improve both poststroke neuroplasticity and outcome [22, 23] .
Only few studies analyzed sleep architecture changes following stroke in both humans and rodents [24] [25] [26] [27] [28] . Reductions in sleep efficiency, total sleep time, sleep spindles, sleep stage 2, and slow-wave sleep (SWS) were suggested to be associated with a poor stroke outcome [29] [30] [31] [32] . However, it remains unclear whether specific sleep stages may specifically modulate stroke evolution in the acute (ischemic cascade), or chronic phase (neuroplasticity) of stroke.
In this study, we aimed to better characterize the impact of ischemic stroke on sleep architecture and whether specific sleep electroencephalogram (EEG) parameters in the acute phase of stroke might predict its outcome. To do so, we chose a translational approach and assessed sleep EEG changes in rodents and humans.
Materials and Methods

Animal study
Male Sprague-Dawley rats (n = 12), 9-11 weeks old and weighing 300 ± 50 g at the time of surgery were used in this study. They were housed under 12-h light/dark cycle (light on 08:00-20:00) with ambient temperature at 22 ± 0.5°C. Food and water were provided ad libitum. All animal procedures were approved by the Animals Research Committee and the Veterinary Office of the Canton of Bern, Switzerland.
In this study, we used rats that had undergone middle cerebral artery occlusion (MCAo), using a permanent occlusion of the artery, which creates a lesion located in the somatosensory cortex (Supplementary Figure S1, D) . Although, this ischemia model does not allow the reperfusion of the artery, which normally happens in stroke patients [33, 34] , it is a reproducible model with low mortality.
Design
Rats were randomly assigned to two experimental groups: (1) ischemia (IS); and (2) sham surgery (Sham). Each experimental group comprised six animals, which were sacrificed after 3 days following ischemic stroke (Supplementary Figure S1, A) . Ischemic stroke was performed at the beginning of the dark period, which reflects the morning, i.e. the beginning of the active period for rats. This time point of stroke surgery was chosen since most often in humans ischemic stroke occurs in the morning during the first few hours of wakefulness [35] (Supplementary Figure S1, A) . The electroencephalogram/electromyogram (EEG/EMG) were recorded continuously for 24 h for a baseline (BL) value (12:12-h dark-light cycle) and for the following 3 days after ischemic stroke in all rats (Supplementary Figure S1 , A and B).
Sleep-wake and circadian EEG assessments
Sleep EEG/architecture was assessed in both IS and Sham groups 24 h before either ischemia or sham surgery, and for the following 3 days after surgery. The EEG/EMG electrodes were implanted as described in our previous study [36] . The EEG/EMG signals were amplified (Grass Instruments) and digitized at a sampling rate of 100 Hz and collected on a PC using VitalRecorder (Kissei Comtec Co. Ltd, Japan). EEG signals were filtered at 0.3 Hz (lowpass filter) and 0.1 KHz (high-pass filter), respectively, whereas EMG, at 1000 Hz. Vigilance states were scored with the SleepSign software (Kissei Comtec Co. Ltd), per 10-s epoch window, as wakefulness (W), non-rapid eye movement (NREM) sleep, or REM sleep as previously described [37] . The overage amount of the sleep stages (W, NREM, and REM sleep) were averaged over 3-h periods for the whole 24-h circadian period of BL and three consecutive days after ischemia/sham surgeries, separately for IS and Sham groups. The percentage of time spent in wakefulness, NREM, and REM was determined for each hour. The total number of sleep bouts and their mean duration were measured across the 24 h of BL and for the following 3 days after ischemic stroke. The behavioral states were scored using the contralateral hemisphere (healthy hemisphere) as previously described [36] . Polysomnographic recordings started immediately after ischemic or sham surgery, although the analysis of the first 30/40 min was excluded because unusual spikes due to isoflurane anesthesia (half-time of isoflurane is <5 min [38] ) were observed in all animals.
Ischemic stroke surgery
Stroke was induced by the three-vessel occlusion method (3Vo) [39] , which predominantly affects the primary somatosensory cortex, avoiding thalamic, hypothalamic, hippocampal, and midbrain damage (Supplementary Figure S1 , D) [33, 34] . 3Vo was performed as previously described [37] . Body temperature was maintained between 36.5 ± 0.5°C with a heating pad. Shamoperated rats were subjected to the same procedure as well as the same time exposure for anesthesia, approximately 90 min, except for the occlusion of the MCA and the common carotid artery (CCA). After surgery rats were returned to their cages and EEG/EMG was resumed until the end of the experiment.
Evaluation of infarct volume
At the end of the experiment, rats were decapitated while deeply anesthetized (isoflurane 5%) and brains dissected and frozen immediately in dry ice. Coronal sections of 20 μm were cut on a cryostat at six predefined levels (L) with 1 mm interval (L-1: 2.7 mm; L-2: 1.7 mm; L-3: 0.7 mm; L-4: −0.3 mm; L-5: −1.3 mm, and L-6: −2.3 mm from bregma) [40, 41] (Supplementary Figure S1, C) . To determine the volume of the lesion, one section from each level was stained with cresyl violet and digitized. The infarct area was measured as previously described [37] .
Human study
Design
This study is a part of the prospective multicenter study SAS-CARE-1 (sleep-disordered breathing in transient ischemic attack [TIA]/ischemic stroke and continuous positive airway pressure [CPAP] treatment efficacy [SAS-CARE]; NCT01097967). The aims and design of the study have been described in details in a recent publication [42] . In short, the SAS-CARE is a multicenter trial, which includes 35-75 years old patients with a clinical diagnosis of TIA or ischemic stroke that are admitted to a stroke unit within 48 h from onset of symptoms. Patients with unstable clinical situation (cardiorespiratory or life-threatening medical conditions), current or past (within the last 3 months before stroke) CPAP treatment, nonischemic event (intracerebral/subarachnoid hemorrhage), and coma/stupor were excluded. After 90 days patients with significant obstructive sleep-disordered breathing (SDB, apnea-hypopnea index [AHI] ≥ 20) are treated with CPAP if sleepy or, if not sleepy, randomized to CPAP treatment or no CPAP treatment. The protocol of the study was approved by the local ethics committee and informed consent was obtained from all participants. For the current study we considered only patients with ischemic stroke.
Selected sleep parameters (Table 2 ) and the following variables were considered: age, sex, cardiovascular risk factors (hypertension, diabetes, dyslipidemia, previous cerebrovascular events, smoking-current or within the past 10 years, atrial fibrillation, and coronary artery disease), body mass index (BMI), sleep-related complaints before stroke (self-reported snoring and Epworth Sleepiness Scale [ESS]) assessed within the first week after admission, National Institutes of Health Stroke Scale (NIHSS) on admission, thrombolysis treatment, topography of current stroke (supratentorial or infratentorial) and etiology according to Trial of Org 10172 in Acute Stroke Treatment (TOAST) study criteria [43] .
Sleep and sleep EEG assessments
Sleep was recorded by video-polysomnography (video-PSG) with EMBLA Titanium System (Titanium, Embla Flaga, Reykjavik, Iceland) and included six channels of electroencephalogram, electromyogram of submental chin and both tibialis anterior muscles, electrooculogram, nasal airflow, abdominal and thoracic efforts, electrocardiogram, and finger pulse oxymetry. Video-PSG was performed within 9 days after stroke for at least 8 h (from 08:00-11:00 pm to 06:00-08:00 am) in the stroke unit or in the sleep laboratory. Recordings were scored manually according to standard criteria [42, 44] . Hypopnea was defined as a reduction in airflow by ≥30% for at least 10 s associated with oxygen desaturation of ≥3%. 
Assessment of neurological outcome
Functional outcome was assessed by the modified Rankin Scale (mRS), which is widely used in clinical practice. The scale ranges from 0 (no symptoms) to 6 (death). A score 2 indicates a slight disability (unable to carry out all previous activities, but able to look after own affairs without assistance). A score 3 indicates a moderate disability, with requirement of some help [45, 46] . Accordingly, and supported by previous studies [13, [47] [48] [49] [50] [51] [52] , a good outcome was defined by a mRS ≤ 2, and a poor outcome by a mRS > 2. Both short-(at discharge) and long-term (3 months after stroke) outcome were assessed. Treatment of SDB was started according to the SAS-CARE study protocol (see above) after the assessment of outcome at 3 months was performed. Clinicians assessing functional outcome were blind to stroke data at admission, as well as sleep study results.
Statistical analyses
Animal study.
Gaussian distribution of values was tested with KolmogorovSmirnov test. Data were presented as mean ± standard error of the mean (SEM). Differences between groups for sleep changes, REM sleep bouts, and duration of sleep bouts at the BL value and for the following 3 days after stroke were evaluated by repeated measures ANOVA. Whenever ANOVA statistical significance was achieved, Fisher's least significant difference (LSD) test was performed. GraphPad Prism6 (GraphPad Prism Software, Inc.) was used for statistical analysis. Type I error α was set at 0.05 (p < 0.05).
Human study
The analysis is based on all patients from the study who had an evaluable BL video-PSG. Continuous variables were expressed as mean ± SD or median (interquartile range [IQR]) depending on the distribution. To assess the relationship between sleep architecture and functional outcome, patients with mRS ≤ 2 were compared to those with mRS > 2, using the unpaired t-test or the Mann-Whitney rank sum test for continuous variables, as appropriate. Chi-square test or the Fisher's exact test was used for categorical variables. The relationships between outcomesmRS (at discharge and at 3 months)-and selected explanatory variables-age, sex, hypertension, diabetes, previous stroke/TIA, stroke topography and etiology, NIHSS on admission, thrombolysis treatment, and sleep parameters (sleep efficiency, REM latency, sleep stages, AHI, and PLMI)-were assessed with multiple linear regression. In specific cases, models were refined using a backward variable selection procedure based on Akaike's Information Criterion. In two patients no REM sleep was observed. For statistical purpose, the REM latency in those patients was imputed as the value of the sleep period time (SPT, amount of time available for sleep after sleep onset).
The significance level of all tests was 5% and no correction for multiplicity was employed. Statistical analysis was performed using R 3.1.2 (R Core Team, Vienna, Austria, 2014).
Results
Animal study
Infarct volume analysis Infarct size was evaluated in the IS group to confirm the presence of the lesion in the brain resulting from the ischemia inducing surgery. The IS group (infarct size: 77.79 ± 5.23 mm 3 [mean ± SEM] data not shown) displayed a lesion mainly located in the cortical area (Supplementary Figure S1 , C). As expected, animals subjected to sham surgery did not show any brain lesions.
Sleep-wake and circadian EEG variables
At the BL recordings we did not observe any statistical differences concerning the circadian distribution of sleep-wake stages, the distributions and hourly amounts of NREM, REM sleep, and waking across the light/dark cycle, between animals that were subsequently randomly divided into the two groups (sham [n = 6] vs.
ischemia surgery [n = 6]). There was no mortality in both groups of animals during the surgery or the recovery time following surgery. Circadian rhythmicity in rodents is in opposite phase compared to humans. At BL recordings, rats exhibited normal diurnal variation in sleep-wake behavior, spending less time in wakefulness and more time in both NREM sleep and REM sleep during the light period than during the dark period of the 24-h light-dark cycle (% of the recording time for NREM sleep: 44.7 ± 1.6 light period, 20.3 ± 0.7 dark period; % of the recording time for REM sleep: 10.3 ± 0.2 light period, 4.9 ± 0.2 dark period; % of the recording time for wake: 47.0 ± 0.7 light period, 71.6 ± 0.9 dark period).
The impact of stroke on the circadian distribution of sleep is summarized daily across the 24-h circadian period in the BL and after three consecutive days after ischemia/sham, for the IS and Sham groups (Figure 1 ). Visual inspection of data across the postsurgical recording period shows that the circadian distribution of sleep in the IS group was generally flattened over the first 24 h following the intervention. Indeed, the IS compared to the Sham group showed a greater proportion of NREM sleep during the dark phase that followed immediately after surgery and which accounts for an active phase for rats. This increase was not observed in the Sham group, although they also received anesthesia. Moreover, a greater proportion of total wakefulness was also observed in the IS group relative to the Sham group during the light phase, which start 12 h after surgery and that accounts for the resting phase for rats. However, sleep-wake behavior recovered over the subsequent dark-light period of days 2 and 3 after ischemic surgeries. Sham control surgeries had little or no effect on sleep EEG (Figure 1 ).
Amount of non-REM, REM sleep, and waking across the light/ dark cycle Figure 2 displays the amount of NREM sleep, REM sleep, and wakefulness assessed separately for the IS and Sham group during 3 days of postsurgical recordings.
During day 1 postsurgery, the total amount of time spent in sleep (including both NREM and REM sleep) and wakefulness over 24 h were unchanged in both IS and Sham groups (Figure 2,  B) . However, separate analyses of NREM sleep and REM sleep revealed significant differences over time between the two groups (IS vs. Sham, Figure 2, A) .
Notably, NREM sleep was significantly increased in the IS group compared to the Sham group and to the BL recording (F(3,15) = 3.52, p = 0.04 interaction "time × group" Figure 1, B) . This increase of NREM sleep in the IS group was observed in the early phase of stroke, during the dark period (i.e. active phase for rats) (Figure 1, A) . However, the total number of NREM sleep bouts and their duration in minutes were unchanged in both groups (Figure 3) .
Conversely, REM sleep was significantly reduced following the 24 h BL after surgery in the IS group (rANOVA: F(3,15) = 7.66, p = 0.002 "time"; Figure 2, B) . Interestingly, when looking at the distributions and hourly amounts of time spent in REM sleep over the first 24 h, REM sleep were unchanged between the two groups in the early dark phase after ischemic stroke (Figure 2, A) . However, a significant decrease of the percentage of REM sleep was observed during the light period (i.e. resting phase for rats), which started 12 h after surgery, in the IS group compared to the Sham group (Figure 2, A) . In addition, also REM sleep bouts were significantly reduced in the IS group compared to the Sham group, without a change in mean REM bout duration (rANOVA: F(3,15) = 5.003, p = 0.01 interaction "time × group"; Figure 3 ).
During day 2 postsurgery, no differences were observed on total amount of sleep ( Figure 2 ) and for the number of total sleep bouts and their duration per minutes (Figure 3) between the IS and Sham groups over the 24 h of the day 2 (Figure 2, B) , i.e. when REM and NREM sleep and wakefulness were individually analyzed.
During day 3 postsurgery, the total amount of sleep over the 24 of the day 3 was unchanged between groups (Figure 2,  A) . However, when looking at the distributions and hourly amounts of the TST, REM sleep, and NREM sleep, significant differences were observed. Mainly, these differences were found at the beginning of the dark period (48-54 h of the day 3, Figure 2 , A) and the start of the light period (60-69 h of the day 3, Figure 2, A) . Interestingly, the total number of sleep bouts, particularly NREM sleep bouts, were significantly increased in the IS group compared to the BL, without a change in their bout duration at day 3 (total sleep 
Human study
Patients characteristics and stroke outcome
A total of 153 patients with acute ischemic stroke were included. The mean age was 61 ± 10 years and 72% were male. The median NIHSS on admission was 3 (IQR: 1-5). Twenty-three (15%) patients had an infratentorial ischemic lesion involving the cerebellum (in 61% of them) and brainstem (39%). Cardioembolism was the most frequent stroke etiology (36%).
A total of 32 (21.1%) patients received thrombolytic therapy. All patients were hospitalized first in the acute stroke unit. The exact use of drugs was available for 73% of patients. In these 111 patients, 4 (3.6%) used antiepileptic drugs, 6 (5.4%) anxiolytics, and 10 (9%) antidepressants.
The mRS was available for 152 patients (99%) at discharge (median 1 [IQR: 0-1]), and for 118 (77%) patients (88 males, 60.7 ± 9.3 years) at 3 months (median 1 [IQR: 0-1]). Twenty-four (16%) patients had poor functional outcome at discharge, and only 6 (5%) at 3 months. Characteristics of the patients are shown in Table 1 .
Sleep and sleep EEG assessments
The results of video-PSG recordings during the acute phase are shown in Table 2 . The mean TST was 319 ± 95 min. Time spent in stage N1 and REM was less than stage N2 and N3. The median AHI and ODI were 15.2 (IQR: 7.3-29.7) and 7.9 (IQR: 2.3-19.6), respectively. Overall, 80% of patients had AHI ≥ 5/h; 40% had an AHI ≥ 20/h, and 25% an AHI ≥ 30/h. Twenty-four (16%) patients had a PLMI ≥ 20/h and 6% a PLMI ≥ 30/h.
Patients with poor functional outcome (mRS > 2) had a lower sleep efficiency (p = 0.006), less amount of REM sleep (p = 0.01), longer REM latency (p = 0.006), and higher AHI (p = 0.04) than patients with good functional outcome (mRS ≤ 2).
In a multiple linear regression analysis, age (p = 0.007), NIHSS on admission (p < 0.001), and REM latency (p = 0.006) were found to be predictors of outcome at discharge. The NIHSS on admission (p = 0.043) and REM latency (p = 0.036) were also independent predictors of mRS at 3 months (Table 3) .
Discussion
In line with previous published studies [24-28, 30, 53, 54] , we found that ischemic stroke significantly alters sleep quantity and sleep EEG/architecture in both humans and animals.
However, we show for the first time, as main findings of this study that ischemic stroke is associated with (1) a significant reduction of REM sleep observed in both humans and animals during the acute phase of stroke, and that (2) this reduction of REM sleep together with a prolonged REM sleep latency is linked with poor outcome in humans.
In animals we found a significant reduction in the total amount of REM sleep as well as the number of REM sleep bouts in the first 24 h following ischemia. This was particularly noticeable during the light period, which started 12 h after ischemic surgery representing the resting phase for rats, and recovered over the time of the experiment. REM sleep was unchanged compared to sham surgery after 2 and 3 days from stroke surgery. Similarly, a suppression of REM sleep during the acute phase of stroke was found previously in different animal species [28, 53, 54] . Noteworthy, a reduction of REM sleep was found in rodent models of stroke involving only cortical [28] or subcortical areas but also with a cortical-subcortical extension of the lesion [53] . Also in humans a reduction in the total amount of REM sleep during the acute phase of stroke was shown by others before [29, 32, 55] . The observation of a link between REM sleep and stroke outcome is however new and in line with a recent study published by our team [36] in which REM sleep was found to correlate negatively with infarct volume in rats [56] [57] [58] .
As in animal models of stroke, also in humans no clear association was found between REM sleep changes and topography of stroke. In this as well as previous studies REM sleep changes were found following both brainstem and supratentorial strokes [59] . While this reduction is usually short-lived in most cases, it may persist beyond the first few days following large hemispheric or strategic brainstem lesions [56] [57] [58] . It is interesting to stress the fact that data on NREM sleep changes following stroke are less consistent. Some studies found an increase of NREM sleep stage 1 and stage 2 [56] [57] [58] , while others showed a reduction in NREM sleep stage 2 [56] [57] [58] and in slow-wave sleep [27] . These discrepancies in results could be partially explained by the differences in methodology. Moreover, the abnormalities in sleep/wake cycles may be influenced by many factors: brain lesion/edema can cause dysfunctions in the sleep regulatory centers; SDB and other sleep disorders (insomnia, restless legs syndrome) that are frequent in stroke patients; comorbidities and others (age, stress, drugs, pain, fever, hospital environmental) [27, 29, 31, 32, 60] . It remains also possible that specific locations of stroke (e.g. in thalamus, caudate nucleus, insula, deep or superficial cortex) and/or its extension may have differential effects on sleep macro-and microstructure [56] [57] [58] 61] and could give new insights into the relationship between this disrupted sleep and stroke outcome. This hypothesis could not be tested in the present study.
The origin of the observed acute reduction of REM sleep could be clarified in our study and remains speculative at this point. Since stroke topography is not relevant, other stroke-related changes must be involved. For example, acute stroke causes the secretion of cytokines from activated microglia at the infarct center [62] during the acute phase of stoke [63] , and cytokines have been shown to suppress REM sleep [64] . These effects could also explain the transitory nature of REM reduction after stroke and the lack of a link with stroke topography.
An additional novel finding is also the observation that REM sleep latency is an independent predictor of stroke short-and long-term outcome. REM latency is influenced by different factors including intra-sleep intrusions of wakefulness, slowwave sleep propensity and circadian factors [65] . An increase in intra-sleep wakefulness, resulting in an increase in REM latency, can be seen in sleep disorders including sleep-related breathing disorder (SDB). In fact, SDB was reported to be associated with a poor stroke recovery in some [51, 66, 67] , but not all studies including the present one [52, [68] [69] [70] . Conversely, we observed a disruption of circadian distribution of sleep in during the acute phase of rodent stroke, which may linked with the change in REM sleep latency. Consistent with this interpretation previous studies showed that stroke [71] as well as traumatic brain injury [72] can alter circadian gene expression patterns in both suprachiasmatic nucleus and hippocampus. Tischkau and collaborators observed in particular that stroke shifts the rhythm of Per1 (period circadian protein homolog 1), known to maintain the circadian rhythms in cell transcripts. Peak expression of Per1 occurred 6 h earlier following stroke, suggesting a role of the circadian clock in stroke pathophysiology [71] . Although we performed a comparative study between humans and animals endeavoring to either reduce or compensate limiting features, it was not impossible to control all of them. Regarding the animal study, the ischemic lesion induced was located exclusively in the left somatosensory cortex, and it would be interesting to know how ischemic stroke, when localized in different brain areas (i.e. only striatal area or cortex and striatum areas), impact sleep and sleep architecture.
Regarding the human study, an unbalanced number of patients with poor and good outcome was available. This is explained by the low stroke severity in our sample and the a priori exclusion of clinically unstable patients. Nevertheless, an association between REM sleep and functional outcome was found even in this sample of mildly affected patients. It remains in addition possible that sleep EEG (including REM) changes may be at least in parts related to the monitoring of patients in the acute stroke unit and by the use of drugs, both of which were not or only partially measured in this study [73, 74] . As psychotropic drugs, in particular the antidepressants, are frequently used by poststroke patients, it is important to taken into account their effects on sleep for better interpretation the polysomnographic findings [74] [75] [76] . Those effects depend upon the type of drug, dosage, time of administration, and duration of the treatment [77] , which were not evaluated in our study. Despite this, the animal model also showed a significant reduction of REM sleep following acute stroke.
Conclusion
Our results showed that acute ischemic stroke is followed by a significant transient reduction of REM sleep in animals, and that the reduction of REM sleep is associated with poor prognosis in humans. Furthermore, an increase in REM latency was found to be an independent predictor of poor outcome. Finally, we also observed in both humans and animals that sleep architecture and the circadian distribution of sleep are disrupted following an ischemic event and may influence the outcome negatively. These findings suggest the need for further research to understand the role of sleep (and in particular REM sleep) in acute stroke.
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